icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 22-26 2022
Back grey_arrow_rt.gif
 
 
 
Improving the pharmacokinetic profile of the hepatitis B virus core inhibitor ABI-H3733 following oral administration: results from new formulation activities
 
 
  EASL 2022 June 22-26 London
 
Michael Shen, Zhixin Zong, Naqvi Mohammed, Katie Zomorodi, Luisa M Stamm, William Delaney, Nicole White Assembly Biosciences, Inc., South San Francisco, CA, USA

0625221

0625222

0625223

0625224

0625225